Acumen Research and Consulting recently published report titled “Spatial Genomics and Transcriptomics Market, Analysis Report and Region Forecast, 2022 - 2030”

LOS ANGELES, Sept. 29, 2022 (GLOBE NEWSWIRE) -- The Global Spatial Genomics & Transcriptomics Market Size accounted for USD 184 Million in 2021 and is estimated to achieve a market size of USD 389 Million by 2030 growing at a CAGR of 8.9% from 2022 to 2030.

Spatial Genomics and Transcriptomics Market Statistics

• Global spatial genomics and transcriptomics market revenue was worth USD 184 million in 2021, with a 8.9% CAGR from 2022 to 2030

• North America region leads with more than 44% spatial genomics and transcriptomics market share in 2021

• Europe region is projected to expand at a CAGR of 9% from 2022 to 2030

• Among technology, the spatial transcriptomics segment has captured 80% of total market in 2021

• By product, the consumable segment accounted for more than 50% of revenue share in 2021
  
  

Request For Free Sample Report @ https://www.acumenresearchandconsulting.com/request-sample/1532

Spatial Genomics and Transcriptomics Market Report Coverage:

Spatial Genomics and Transcriptomics Market Overview

Spatial genomics and transcriptomics enable researchers to view not just what is within a cell, but also how cells are structured in relation to one another, providing crucial insights into disease through the utilization of data that was previously beyond of reach of current methodologies. Transcriptomic investigation and assortment are included in spatial genomics and transcriptomics.

Spatial Genomics and Transcriptomics Market Growth Factors

• Rising potential of spatial genomic analysis as a cancer diagnosis technique

• Increasing drug development and discovery efforts by pharmaceutical companies

• The launch of new products, as well as customer awareness of them
  
  

Spatial Genomics and Transcriptomics Market Dynamics

Current genetic instrument improvements, as well as increased investment in genomes and transcriptome research, are major drivers of market expansion in cumulative demand for robust cancer diagnostic alternatives. Furthermore, new and start-up genomic firms are attempting to address the increased demand for sophisticated technologies to explore spatial patterns by developing new products.

For example, GeoMx Digitally Spatial Profiler is scheduled for 2019 by NanoString Technologies. Moreover, corporations are forming strategic alliances in order to capitalize on untapped market potential. Spatial Transcriptomics and Seven Bridges formed a collaboration in April 2017 to create a comprehensive visualizational tool for monitoring gene expression within tissue samples.

In disease management, spatial genomics has excellent potential as it assists in providing quantitative genetic expression information, together with visualized DNA & RNA mapping within parts of the tissue. In turn, this generates profitable possibilities for companies to introduce spatially resolved diagnostic and translational research transcriptomics and Genomics-based techniques.

Spatial Genomics and Transcriptomics Market Share

In translation theory, spatial genomics and transcriptomics generated the most revenue shares in 2018. Key vendors provide scientists with various channels for assessment in genetic investigations, as well as access and income production for large-scale biomedical data. Current research into the morphometric status of cells when diagnosing disorders provides university clientele with substantial business growth opportunities.

Check the detailed table of contents of the report @

https://www.acumenresearchandconsulting.com/table-of-content/spatial-genomics-and-transcriptomics-market

Spatial Genomics and Transcriptomics Market Segmentation

The global spatial genomics and transcriptomics market has been segmented by Acumen Research and Consulting based on product, technology, and end-use. By product, the segment is separated into instruments [by type (IHC, sequencing platforms, mass spectrometry, microscopy, flow cytometry, and others), and by mode (manual, semi-automated, and automated)], software [imaging tools, bioinformatics tools, and storage and management databases], and consumables. Consumables accounted for the largest percentage of revenue due to increased product penetration and widespread availability of reagents & kits for conducting investigations. Simultaneously, strategic partnerships between players, such as the acquisition of Illumina's Edico Genome in May 2018 to accelerate genetic information assessment, result in a faster rate of software product development.

In terms of technology, the market is further categorized into spatial transcriptomics [sequencing-based methods (in situ sequencing, laser capture microdissection (LCM), microtomy sequencing, and transcriptome in-vivo analysis (TIVA)), microscopy-based RNA imaging techniques (padlock probes/ rolling circle amplification, single molecule RNA fluorescence in-situ hybridization, and branched DNA probes), and IHC], and Spatial genomics [microscopy-based live DNA Imaging, FISH, massively-parallel sequencing, genome perturbation tools, biochemical techniques, and others]. Advances in genome disruption instruments promote FISH use, resulting in the largest percentage of technology profits. Parallel processing sequencing, on the other hand, results in increased output at low cost, and segment advancement is likely to be complemented soon by fast CAGR. Moreover, the huge number of available sequence platforms for studying RNA architecture in tissue or cells was critical for spatial transcriptomics. However, IHC approaches are expected to have the most commercial penetration because they are not well adapted to spatial omics investigation yet have low-performance sequencing.

Based on the end-use, the industry is further divided into the pharmaceutical manufacturer, translational research, academic customers, and diagnostic customers. According to the spatial genomics and transcriptomics market forecast, the pharmaceutical manufacturer segment is expected to grow significantly in market over the forecasting years.

Spatial Genomics and Transcriptomics Market Regional Overview

The global spatial genomics and transcriptomics market is separated into several geographic regions: North America, Latin America, Europe, Asia-Pacific, and the Middle East and Africa. According to spatial genomics and transcriptomics industry analysis, North America led the global market and is expected to maintain its largest sales share in 2021. The company continues to invest in cancer research due to the high demand in the United States for better diagnostic and therapy approaches.

Besides that, the Asia-Pacific region is expected to have the most growth in the market during the forecast period. Expanding geographically and establishing low-cost manufacturing & operational facilities in the region's growing economies are businesses from established areas.

Buy this premium research report –

https://www.acumenresearchandconsulting.com/buy-now/0/1532

Spatial Genomics and Transcriptomics Market Players

Some of the prominent spatial genomics and transcriptomics market companies are NanoString Technologies, S2 Genomics, Inc., CARTANA AB, Illumina, Inc., Dovetail Genomics, Seven Bridges Genomic, 10x Genomics, Horizon Discovery Group plc, and Advanced Cell Diagnostics.

Spatial Genomics and Transcriptomics Market Strategies

• Mature organizations are working on new platforms to maintain their market position. Government assistance assists new players in expanding their product offerings. S2 Genomics, for example, received a Phase I STTR grant from the National Institute of Health in June 2018 for the development of a singular system to streamline the fabrication of single kernels.
  
  

Questions Answered By This Report

• What was the market size of Spatial Genomics and Transcriptomics Market in 2021?

• What will be the CAGR of Spatial Genomics and Transcriptomics Market during the forecast period from 2022 to 2030?

• Who are the major players in Global Spatial Genomics and Transcriptomics Market?

• Which region held the largest share in Spatial Genomics and Transcriptomics Market in 2021?

• What are the key market drivers of Spatial Genomics and Transcriptomics Market?

• Who is the largest end user Spatial Genomics and Transcriptomics Market?

• What will be the Spatial Genomics and Transcriptomics Market value in 2030?
  
  

Browse More Research Topic on Healthcare Sector:

The Global Anastomosis Devices Market accounted for USD 2,219 Million in 2020 and is expected to reach USD 3,822 Million by 2028 with a considerable CAGR of 7.1% during the forecast period of 2021 to 2028.

The Global Human Chorionic Gonadotropin Market accounted for USD 874 Million in 2020 and is expected to reach USD 1,534 Million by 2028 with a considerable CAGR of 7.4% during the predicted period of 2021 to 2028.

The Global Biliary Stents Market accounted for around USD 345 Million in 2020 and is expected to reach USD 510 Million by 2028 with a considerable CAGR of 5.3% during the forecast period of 2021 to 2028.

About Acumen Research and Consulting:

Acumen Research and Consulting is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact-based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

For Latest Update Follow Us on Twitter and, LinkedIn

Contact Us:

Mr. Richard Johnson

Acumen Research and Consulting

USA: +13474743864

India: +918983225533

E-mail: sales@acumenresearchandconsulting.com